Biosergen AB (publ) (STO:BIOSGN)
Sweden · Delayed Price · Currency is SEK 5.45
+1.75 (47.30%)
Aug 13, 2026, 5:29 PM CET
Biosergen AB Market Cap
Biosergen AB has a market cap or net worth of 12.8 million as of August 13, 2026. Its market cap has decreased by -88.95% in one year.
Market Cap
12.80M
Enterprise Value
-2.57M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5.45
ChartMarket Cap Chart
Since June 24, 2021, Biosergen AB's market cap has decreased from 197.72M to 12.80M, a decrease of -93.53%. That is a compound annual growth rate of -41.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 13, 2026 | 12.80M | -86.21% |
| Dec 30, 2025 | 92.80M | -25.43% |
| Dec 30, 2024 | 124.46M | 179.03% |
| Dec 29, 2023 | 44.60M | 0.12% |
| Dec 30, 2022 | 44.55M | -70.75% |
| Dec 30, 2021 | 152.31M | -22.97% |
| Jun 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Pila Pharma AB | 61.44M |
| Disruptive Pharma AB | 59.21M |
| 2cureX AB | 51.56M |
| Modus Therapeutics Holding AB | 46.58M |
| Fluicell AB | 40.11M |
| ExpreS2ion Biotech Holding AB | 34.67M |
| Alligator Bioscience AB | 23.11M |
| NanoEcho AB | 14.82M |